Tuberculosis and lung damage: from epidemiology to pathophysiology

European Respiratory Review : an Official Journal of the European Respiratory Society
Shruthi RavimohanGregory P Bisson

Abstract

A past history of pulmonary tuberculosis (TB) is a risk factor for long-term respiratory impairment. Post-TB lung dysfunction often goes unrecognised, despite its relatively high prevalence and its association with reduced quality of life. Importantly, specific host and pathogen factors causing lung impairment remain unclear. Host immune responses probably play a dominant role in lung damage, as excessive inflammation and elevated expression of lung matrix-degrading proteases are common during TB. Variability in host genes that modulate these immune responses may determine the severity of lung impairment, but this hypothesis remains largely untested. In this review, we provide an overview of the epidemiological literature on post-TB lung impairment and link it to data on the pathogenesis of lung injury from the perspective of dysregulated immune responses and immunogenetics.

References

Mar 1, 1991·Tubercle·G A Rook, R al Attiyah
May 1, 1989·Respiratory Medicine·P A Willcox, A D Ferguson
Jul 7, 1994·The New England Journal of Medicine·R O Crapo
Nov 14, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D P DooleyS Rademacher
Jan 5, 1999·American Journal of Respiratory and Critical Care Medicine·M CasariniS Giosuè
Nov 30, 1999·Journal of Leukocyte Biology·C FratazziH G Remold
Aug 10, 2000·American Journal of Respiratory and Critical Care Medicine·M WhyteF Di Giovine
Mar 5, 2002·Human Molecular Genetics·Ladina JoosAndrew J Sandford
Feb 27, 2003·Antimicrobial Agents and Chemotherapy·Jacques Grosset
Mar 26, 2003·Infection and Immunity·Jennifer L TaylorIan M Orme
May 15, 2003·American Journal of Respiratory and Critical Care Medicine·Antoni XaubetCesar Picado
Sep 1, 1961·Archives of Internal Medicine·J H ANGELH A LYONS
Mar 6, 2004·Science·Volker BrinkmannArturo Zychlinsky
Feb 26, 2005·Infection and Immunity·Evgenyi B EruslanovAlexander S Apt
Aug 2, 2005·The European Respiratory Journal·M R MillerUNKNOWN ATS/ERS Task Force
Sep 2, 2005·The Journal of Infectious Diseases·Keertan DhedaGraham A W Rook
Oct 6, 2005·The European Respiratory Journal·N MacintyreJ Wanger
Oct 8, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Paul T G ElkingtonJon S Friedland
Nov 3, 2005·The European Respiratory Journal·R PellegrinoJ Wanger
Dec 20, 2005·Tuberculosis·Kris L HelkeYukari C Manabe
Jan 24, 2006·Molecular and Cellular Biology·Arnaud DidierlaurentKimberly Burns
Jan 24, 2007·Physiological Reviews·Kendra J GreenleeFarrah Kheradmand
Apr 3, 2007·Chest·Jotam G PasipanodyaStephen E Weis
May 18, 2007·American Journal of Respiratory and Critical Care Medicine·Klaus F RabeUNKNOWN Global Initiative for Chronic Obstructive Lung Disease
Jun 19, 2007·American Journal of Respiratory Cell and Molecular Biology·Paul T ElkingtonJon S Friedland
Sep 7, 2007·The European Respiratory Journal·A M B MenezesUNKNOWN Latin American Project for the Investigation of Obstructive Lung Disease (PLATINO) Team
Sep 19, 2007·Respirology : Official Journal of the Asian Pacific Society of Respirology·Márcia SeiscentoLisete R Teixeira

❮ Previous
Next ❯

Citations

Feb 16, 2019·Immunology and Cell Biology·Franz PutturClare M Lloyd
Nov 14, 2019·Cellular and Molecular Life Sciences : CMLS·Qiyao ChaiCui Hua Liu
Nov 22, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Shruthi RavimohanGregory P Bisson
Sep 26, 2019·Annals of the American Thoracic Society·Martha PowersAna Navas-Acien
Jan 29, 2020·Tropical Medicine & International Health : TM & IH·Grace McHughUNKNOWN BREATHE Clinical Trial Team
Feb 29, 2020·The Journal of Pathology·Liana Tsenova, Amit Singhal
Oct 9, 2019·Journal of Applied Microbiology·R SinghT Prasad
Jun 20, 2020·Antioxidants & Redox Signaling·Eduardo P AmaralBruno B Andrade
Dec 13, 2019·PloS One·Breanne M HeadZulma Vanessa Rueda
Jun 27, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Shruthi RavimohanGregory P Bisson
May 10, 2020·BMC Pulmonary Medicine·Celso KhosaAndrea Rachow
Jun 17, 2020·Frontiers in Immunology·Caleb N Muefong, Jayne S Sutherland
Jul 21, 2020·The Nigerian Postgraduate Medical Journal·Olutobi Babatope OjuawoAlakija Kazeem Salami
Sep 4, 2020·Phytotherapy Research : PTR·Sai Manohar ThotaVenketesh Sivaramakrishnan
Sep 29, 2020·International Journal of Chronic Obstructive Pulmonary Disease·Abdullah Al-HarbiHamdan Al-Jahdali
Nov 6, 2020·British Journal of Pharmacology·Farha Naz, Mohd Arish
Jan 6, 2021·Annals of Nuclear Medicine·Philippa L BresserMike M Sathekge
Nov 17, 2019·Trends in Immunology·Valentina Guerrini, Maria Laura Gennaro
Nov 28, 2020·Tuberculosis·Gabriel Tassi MousquerMarilu Fiegenbaum
Oct 23, 2020·Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences·Sayyed Gholamreza Mortazavi MoghaddamMahmood Zardast
Feb 26, 2021·MSphere·Mansour Kargarpour KamakoliFarzam Vaziri
Jun 3, 2020·The Lancet Infectious Diseases·Michael E UrbanowskiWilliam R Bishai
May 7, 2021·Frontiers in Immunology·Stefanie KrugWilliam R Bishai
May 18, 2021·Archivos De Bronconeumología·Sara Castillo-AcostaJorge Lorenzo Freixinet-Gilart
Nov 3, 2020·EClinicalMedicine·Lucia CilloniNimalan Arinaminpathy
Jun 30, 2021·Current Opinion in Pharmacology·Michele MondoniGiovanni Sotgiu

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies
bronchoalveolar lavage

Software Mentioned

PIAT

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Opinion in Pulmonary Medicine
Aran SinganayagamSebastian L Johnston
Critical Care : the Official Journal of the Critical Care Forum
Philip TonerMurali Shyamsundar
Revista brasileira de reumatologia
Roberto Ezequiel Heymann, Marcos Renato de Assis
Journal of the American College of Cardiology
William W Parmley
© 2022 Meta ULC. All rights reserved